About Covance

As the drug development business of Laboratory Corporation of America Holdings (Labcorp) and the world’s most comprehensive drug development #CRO service company, we have helped pharmaceutical and biotech companies develop 100% of the top 50 prescription drugs in the marketplace today.

Because of our broad experience and specialized expertise, we’re in a unique position to supply insights that go above and beyond testing. Together with our clients, we create solutions that transform potential into reality.

website icon
Website
employees icon
Employees
5,001-10,000 employees View all Covance employees link out icon
industry icon
Industry
Research
location icon
Location
206 Carnegie Center Dr, Princeton, New Jersey 08540, US
description icon
Founded
1996
description icon
Keywords
Pharmacovigilance, Cro, Clinical Trials, Biotech, Pediatrics, Life Sciences, Pharmaceuticals, Market Access, Clinical Research, Oncology, Inflammation, Commercialization, Drug Testing, Infectious Diseases, Bioanalysis, Biologics, Rare Disease, Crop Protection, Kidney Disease, Cardiovascular, Orphan Drugs, Bioassays, Immuno-Oncology, Drug Development Services, Nash, Cell And Gene Therapy, Central Laboratory Services, Clinical Trial Management Services, Toxicology Services, Small Molecule, Phase I-Iia, Phase Ii-Iii, Preclinical Solutions, Cl

Frequently Asked Questions about Covance

Who is the CEO of Covance?

Elissa Hahn is the CEO of Covance. To contact Elissa Hahn email at [email protected].

Who are the decision makers in Covance?

The decision makers in Covance are Greg Hall, Herman Scholtz, Honggang Bi, etc. Click to Find Covance decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more